|
Fusion Gene Summary | |
Fusion Gene ORF analysis | |
Fusion Genomic Features | |
Fusion Protein Features | |
Fusion Gene Sequence | |
Fusion Gene PPI analysis | |
Related Drugs | |
Related Diseases |
Fusion gene:PRMT2-SLC41A2 (FusionGDB2 ID:68924) |
Fusion Gene Summary for PRMT2-SLC41A2 |
Fusion gene summary |
Fusion gene information | Fusion gene name: PRMT2-SLC41A2 | Fusion gene ID: 68924 | Hgene | Tgene | Gene symbol | PRMT2 | SLC41A2 | Gene ID | 3275 | 84102 |
Gene name | protein arginine methyltransferase 2 | solute carrier family 41 member 2 | |
Synonyms | HRMT1L1 | SLC41A1-L1 | |
Cytomap | 21q22.3 | 12q23.3 | |
Type of gene | protein-coding | protein-coding | |
Description | protein arginine N-methyltransferase 2HMT1 (hnRNP methyltransferase, S. cerevisiae)-like 1HMT1 hnRNP methyltransferase-like 1PRMT2 alphaPRMT2 betaPRMT2 gammahistone-arginine N-methyltransferase PRMT2 | solute carrier family 41 member 2SLC41A1-like 1solute carrier family 41 (magnesium transporter), member 2 | |
Modification date | 20200313 | 20200313 | |
UniProtAcc | . | . | |
Ensembl transtripts involved in fusion gene | ENST00000491389, ENST00000291705, ENST00000334494, ENST00000355680, ENST00000397628, ENST00000397637, ENST00000397638, ENST00000440086, ENST00000451211, ENST00000458387, | ENST00000258538, ENST00000549713, | |
Fusion gene scores | * DoF score | 11 X 9 X 7=693 | 3 X 3 X 4=36 |
# samples | 12 | 4 | |
** MAII score | log2(12/693*10)=-2.5298209465287 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(4/36*10)=0.15200309344505 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
Context | PubMed: PRMT2 [Title/Abstract] AND SLC41A2 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | PRMT2(48069651)-SLC41A2(105199115), # samples:1 | ||
Anticipated loss of major functional domain due to fusion event. | PRMT2-SLC41A2 seems lost the major protein functional domain in Hgene partner, which is a epigenetic factor due to the frame-shifted ORF. PRMT2-SLC41A2 seems lost the major protein functional domain in Hgene partner, which is a essential gene due to the frame-shifted ORF. PRMT2-SLC41A2 seems lost the major protein functional domain in Hgene partner, which is a IUPHAR drug target due to the frame-shifted ORF. PRMT2-SLC41A2 seems lost the major protein functional domain in Tgene partner, which is a essential gene due to the frame-shifted ORF. PRMT2-SLC41A2 seems lost the major protein functional domain in Tgene partner, which is a IUPHAR drug target due to the frame-shifted ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | PRMT2 | GO:0016571 | histone methylation | 19405910 |
Hgene | PRMT2 | GO:0032088 | negative regulation of NF-kappaB transcription factor activity | 16648481 |
Hgene | PRMT2 | GO:0045892 | negative regulation of transcription, DNA-templated | 16648481 |
Hgene | PRMT2 | GO:0045893 | positive regulation of transcription, DNA-templated | 12039952 |
Hgene | PRMT2 | GO:0060765 | regulation of androgen receptor signaling pathway | 17587566 |
Fusion gene breakpoints across PRMT2 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene breakpoints across SLC41A2 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | BRCA | TCGA-AN-A0AL-01A | PRMT2 | chr21 | 48069651 | + | SLC41A2 | chr12 | 105199115 | - |
Top |
Fusion Gene ORF analysis for PRMT2-SLC41A2 |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
3UTR-3CDS | ENST00000491389 | ENST00000258538 | PRMT2 | chr21 | 48069651 | + | SLC41A2 | chr12 | 105199115 | - |
3UTR-5UTR | ENST00000491389 | ENST00000549713 | PRMT2 | chr21 | 48069651 | + | SLC41A2 | chr12 | 105199115 | - |
5CDS-5UTR | ENST00000291705 | ENST00000549713 | PRMT2 | chr21 | 48069651 | + | SLC41A2 | chr12 | 105199115 | - |
5CDS-5UTR | ENST00000334494 | ENST00000549713 | PRMT2 | chr21 | 48069651 | + | SLC41A2 | chr12 | 105199115 | - |
5CDS-5UTR | ENST00000355680 | ENST00000549713 | PRMT2 | chr21 | 48069651 | + | SLC41A2 | chr12 | 105199115 | - |
5CDS-5UTR | ENST00000397628 | ENST00000549713 | PRMT2 | chr21 | 48069651 | + | SLC41A2 | chr12 | 105199115 | - |
5CDS-5UTR | ENST00000397637 | ENST00000549713 | PRMT2 | chr21 | 48069651 | + | SLC41A2 | chr12 | 105199115 | - |
5CDS-5UTR | ENST00000397638 | ENST00000549713 | PRMT2 | chr21 | 48069651 | + | SLC41A2 | chr12 | 105199115 | - |
5CDS-5UTR | ENST00000440086 | ENST00000549713 | PRMT2 | chr21 | 48069651 | + | SLC41A2 | chr12 | 105199115 | - |
5CDS-5UTR | ENST00000451211 | ENST00000549713 | PRMT2 | chr21 | 48069651 | + | SLC41A2 | chr12 | 105199115 | - |
5CDS-5UTR | ENST00000458387 | ENST00000549713 | PRMT2 | chr21 | 48069651 | + | SLC41A2 | chr12 | 105199115 | - |
Frame-shift | ENST00000397628 | ENST00000258538 | PRMT2 | chr21 | 48069651 | + | SLC41A2 | chr12 | 105199115 | - |
In-frame | ENST00000291705 | ENST00000258538 | PRMT2 | chr21 | 48069651 | + | SLC41A2 | chr12 | 105199115 | - |
In-frame | ENST00000334494 | ENST00000258538 | PRMT2 | chr21 | 48069651 | + | SLC41A2 | chr12 | 105199115 | - |
In-frame | ENST00000355680 | ENST00000258538 | PRMT2 | chr21 | 48069651 | + | SLC41A2 | chr12 | 105199115 | - |
In-frame | ENST00000397637 | ENST00000258538 | PRMT2 | chr21 | 48069651 | + | SLC41A2 | chr12 | 105199115 | - |
In-frame | ENST00000397638 | ENST00000258538 | PRMT2 | chr21 | 48069651 | + | SLC41A2 | chr12 | 105199115 | - |
In-frame | ENST00000440086 | ENST00000258538 | PRMT2 | chr21 | 48069651 | + | SLC41A2 | chr12 | 105199115 | - |
In-frame | ENST00000451211 | ENST00000258538 | PRMT2 | chr21 | 48069651 | + | SLC41A2 | chr12 | 105199115 | - |
In-frame | ENST00000458387 | ENST00000258538 | PRMT2 | chr21 | 48069651 | + | SLC41A2 | chr12 | 105199115 | - |
ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000355680 | PRMT2 | chr21 | 48069651 | + | ENST00000258538 | SLC41A2 | chr12 | 105199115 | - | 4201 | 1416 | 762 | 1601 | 279 |
ENST00000397638 | PRMT2 | chr21 | 48069651 | + | ENST00000258538 | SLC41A2 | chr12 | 105199115 | - | 3644 | 859 | 205 | 1044 | 279 |
ENST00000291705 | PRMT2 | chr21 | 48069651 | + | ENST00000258538 | SLC41A2 | chr12 | 105199115 | - | 3614 | 829 | 175 | 1014 | 279 |
ENST00000458387 | PRMT2 | chr21 | 48069651 | + | ENST00000258538 | SLC41A2 | chr12 | 105199115 | - | 3614 | 829 | 175 | 1014 | 279 |
ENST00000451211 | PRMT2 | chr21 | 48069651 | + | ENST00000258538 | SLC41A2 | chr12 | 105199115 | - | 3614 | 829 | 175 | 1014 | 279 |
ENST00000397637 | PRMT2 | chr21 | 48069651 | + | ENST00000258538 | SLC41A2 | chr12 | 105199115 | - | 4393 | 1608 | 954 | 1793 | 279 |
ENST00000334494 | PRMT2 | chr21 | 48069651 | + | ENST00000258538 | SLC41A2 | chr12 | 105199115 | - | 3606 | 821 | 167 | 1006 | 279 |
ENST00000440086 | PRMT2 | chr21 | 48069651 | + | ENST00000258538 | SLC41A2 | chr12 | 105199115 | - | 3578 | 793 | 139 | 978 | 279 |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000355680 | ENST00000258538 | PRMT2 | chr21 | 48069651 | + | SLC41A2 | chr12 | 105199115 | - | 0.001726466 | 0.9982735 |
ENST00000397638 | ENST00000258538 | PRMT2 | chr21 | 48069651 | + | SLC41A2 | chr12 | 105199115 | - | 0.001184242 | 0.9988158 |
ENST00000291705 | ENST00000258538 | PRMT2 | chr21 | 48069651 | + | SLC41A2 | chr12 | 105199115 | - | 0.001152768 | 0.99884725 |
ENST00000458387 | ENST00000258538 | PRMT2 | chr21 | 48069651 | + | SLC41A2 | chr12 | 105199115 | - | 0.001152768 | 0.99884725 |
ENST00000451211 | ENST00000258538 | PRMT2 | chr21 | 48069651 | + | SLC41A2 | chr12 | 105199115 | - | 0.001152768 | 0.99884725 |
ENST00000397637 | ENST00000258538 | PRMT2 | chr21 | 48069651 | + | SLC41A2 | chr12 | 105199115 | - | 0.001655238 | 0.9983448 |
ENST00000334494 | ENST00000258538 | PRMT2 | chr21 | 48069651 | + | SLC41A2 | chr12 | 105199115 | - | 0.001146504 | 0.99885345 |
ENST00000440086 | ENST00000258538 | PRMT2 | chr21 | 48069651 | + | SLC41A2 | chr12 | 105199115 | - | 0.001195152 | 0.9988048 |
Top |
Fusion Genomic Features for PRMT2-SLC41A2 |
FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for PRMT2-SLC41A2 |
Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr21:48069651/chr12:105199115) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
. | . |
FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. | FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | PRMT2 | chr21:48069651 | chr12:105199115 | ENST00000334494 | + | 6 | 7 | 30_89 | 218 | 285.0 | Domain | SH3 |
Hgene | PRMT2 | chr21:48069651 | chr12:105199115 | ENST00000355680 | + | 7 | 12 | 30_89 | 218 | 434.0 | Domain | SH3 |
Hgene | PRMT2 | chr21:48069651 | chr12:105199115 | ENST00000397637 | + | 6 | 11 | 30_89 | 218 | 434.0 | Domain | SH3 |
Hgene | PRMT2 | chr21:48069651 | chr12:105199115 | ENST00000397638 | + | 6 | 11 | 30_89 | 218 | 434.0 | Domain | SH3 |
Hgene | PRMT2 | chr21:48069651 | chr12:105199115 | ENST00000440086 | + | 6 | 9 | 30_89 | 218 | 332.0 | Domain | SH3 |
Tgene | SLC41A2 | chr21:48069651 | chr12:105199115 | ENST00000258538 | 8 | 10 | 520_543 | 512 | 574.0 | Topological domain | Extracellular | |
Tgene | SLC41A2 | chr21:48069651 | chr12:105199115 | ENST00000258538 | 8 | 10 | 565_573 | 512 | 574.0 | Topological domain | Cytoplasmic | |
Tgene | SLC41A2 | chr21:48069651 | chr12:105199115 | ENST00000258538 | 8 | 10 | 544_564 | 512 | 574.0 | Transmembrane | Helical |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | PRMT2 | chr21:48069651 | chr12:105199115 | ENST00000334494 | + | 6 | 7 | 99_432 | 218 | 285.0 | Domain | SAM-dependent MTase PRMT-type |
Hgene | PRMT2 | chr21:48069651 | chr12:105199115 | ENST00000355680 | + | 7 | 12 | 99_432 | 218 | 434.0 | Domain | SAM-dependent MTase PRMT-type |
Hgene | PRMT2 | chr21:48069651 | chr12:105199115 | ENST00000397637 | + | 6 | 11 | 99_432 | 218 | 434.0 | Domain | SAM-dependent MTase PRMT-type |
Hgene | PRMT2 | chr21:48069651 | chr12:105199115 | ENST00000397638 | + | 6 | 11 | 99_432 | 218 | 434.0 | Domain | SAM-dependent MTase PRMT-type |
Hgene | PRMT2 | chr21:48069651 | chr12:105199115 | ENST00000440086 | + | 6 | 9 | 99_432 | 218 | 332.0 | Domain | SAM-dependent MTase PRMT-type |
Tgene | SLC41A2 | chr21:48069651 | chr12:105199115 | ENST00000258538 | 8 | 10 | 184_195 | 512 | 574.0 | Topological domain | Cytoplasmic | |
Tgene | SLC41A2 | chr21:48069651 | chr12:105199115 | ENST00000258538 | 8 | 10 | 1_162 | 512 | 574.0 | Topological domain | Extracellular | |
Tgene | SLC41A2 | chr21:48069651 | chr12:105199115 | ENST00000258538 | 8 | 10 | 217_245 | 512 | 574.0 | Topological domain | Extracellular | |
Tgene | SLC41A2 | chr21:48069651 | chr12:105199115 | ENST00000258538 | 8 | 10 | 267_282 | 512 | 574.0 | Topological domain | Cytoplasmic | |
Tgene | SLC41A2 | chr21:48069651 | chr12:105199115 | ENST00000258538 | 8 | 10 | 304_313 | 512 | 574.0 | Topological domain | Extracellular | |
Tgene | SLC41A2 | chr21:48069651 | chr12:105199115 | ENST00000258538 | 8 | 10 | 335_347 | 512 | 574.0 | Topological domain | Cytoplasmic | |
Tgene | SLC41A2 | chr21:48069651 | chr12:105199115 | ENST00000258538 | 8 | 10 | 369_376 | 512 | 574.0 | Topological domain | Extracellular | |
Tgene | SLC41A2 | chr21:48069651 | chr12:105199115 | ENST00000258538 | 8 | 10 | 398_406 | 512 | 574.0 | Topological domain | Cytoplasmic | |
Tgene | SLC41A2 | chr21:48069651 | chr12:105199115 | ENST00000258538 | 8 | 10 | 428_469 | 512 | 574.0 | Topological domain | Extracellular | |
Tgene | SLC41A2 | chr21:48069651 | chr12:105199115 | ENST00000258538 | 8 | 10 | 491_498 | 512 | 574.0 | Topological domain | Cytoplasmic | |
Tgene | SLC41A2 | chr21:48069651 | chr12:105199115 | ENST00000258538 | 8 | 10 | 163_183 | 512 | 574.0 | Transmembrane | Helical | |
Tgene | SLC41A2 | chr21:48069651 | chr12:105199115 | ENST00000258538 | 8 | 10 | 196_216 | 512 | 574.0 | Transmembrane | Helical | |
Tgene | SLC41A2 | chr21:48069651 | chr12:105199115 | ENST00000258538 | 8 | 10 | 246_266 | 512 | 574.0 | Transmembrane | Helical | |
Tgene | SLC41A2 | chr21:48069651 | chr12:105199115 | ENST00000258538 | 8 | 10 | 283_303 | 512 | 574.0 | Transmembrane | Helical | |
Tgene | SLC41A2 | chr21:48069651 | chr12:105199115 | ENST00000258538 | 8 | 10 | 314_334 | 512 | 574.0 | Transmembrane | Helical | |
Tgene | SLC41A2 | chr21:48069651 | chr12:105199115 | ENST00000258538 | 8 | 10 | 348_368 | 512 | 574.0 | Transmembrane | Helical | |
Tgene | SLC41A2 | chr21:48069651 | chr12:105199115 | ENST00000258538 | 8 | 10 | 377_397 | 512 | 574.0 | Transmembrane | Helical | |
Tgene | SLC41A2 | chr21:48069651 | chr12:105199115 | ENST00000258538 | 8 | 10 | 407_427 | 512 | 574.0 | Transmembrane | Helical | |
Tgene | SLC41A2 | chr21:48069651 | chr12:105199115 | ENST00000258538 | 8 | 10 | 470_490 | 512 | 574.0 | Transmembrane | Helical | |
Tgene | SLC41A2 | chr21:48069651 | chr12:105199115 | ENST00000258538 | 8 | 10 | 499_519 | 512 | 574.0 | Transmembrane | Helical |
Top |
Fusion Gene Sequence for PRMT2-SLC41A2 |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
>68924_68924_1_PRMT2-SLC41A2_PRMT2_chr21_48069651_ENST00000291705_SLC41A2_chr12_105199115_ENST00000258538_length(transcript)=3614nt_BP=829nt GGCCTGCGTGCACTGCGCTTGCGCGGGTTGAGGGCGGTGGCTCAGGCTCCTGGAAAGGACCGTCCACCCCTCCGCGCTGGCGGTGTGGAC GCGGAACTCAGCGGAGAAACGCGATTGAGAAATGGAAAAGAAAATGAAATAAATCAGCAGTTATGAGGCAGAGCCTAAGAGAACTATGGC AACATCAGGTGACTGTCCCAGAAGTGAATCGCAGGGAGAAGAGCCTGCTGAGTGCAGTGAGGCCGGTCTCCTGCAGGAGGGAGTACAGCC AGAGGAGTTTGTGGCCATCGCGGACTACGCTGCCACCGATGAGACCCAGCTCAGTTTTTTGAGAGGAGAAAAAATTCTTATCCTGAGACA AACCACTGCAGATTGGTGGTGGGGTGAGCGTGCGGGCTGCTGTGGGTACATTCCGGCAAACCATGTGGGGAAGCACGTGGATGAGTACGA CCCCGAGGACACGTGGCAGGATGAAGAGTACTTCGGCAGCTATGGAACTCTGAAACTCCACTTGGAGATGTTGGCAGACCAGCCACGAAC AACTAAATACCACAGTGTCATCCTGCAGAATAAAGAATCCCTGACGGATAAAGTCATCCTGGACGTGGGCTGTGGGACTGGGATCATCAG TCTCTTCTGTGCACACTATGCGCGGCCTAGAGCGGTGTACGCGGTGGAGGCCAGTGAGATGGCACAGCACACGGGGCAGCTGGTCCTGCA GAACGGCTTTGCTGACATCATCACCGTGTACCAGCAGAAGGTGGAGGATGTGGTGCTGCCCGAGAAGGTGGACGTGCTGGTGTCTGAGTG GATGGGGACCTGCCTGCTGGTATTTACCTTGCTGTGGATTGCTGACTGGATGGTCCATCACTTCTGGAGGAAAGGAAAGGACCCGGATAG TTTCTCCATCCCCTACCTAACAGCATTGGGTGATCTGCTCGGGACAGCTCTGTTAGCCTTAAGTTTTCATTTTCTTTGGCTTATTGGAGA TCGAGATGGAGATGTTGGAGACTAATAAATTCTACAAACTGCTCTCAAGTTACCAAGGAAGAAAATACACGACAACCACTTATGGCTCTT TTTCAAAACTCTTAAATCAGTAGTTTGACTTTTGCCAGGGTAATCTTCAGTTGGCCCTGATTCAATTAAATGGCCTTAATTTTTTTTTAA GGAATTTGTGTCAAAACCAGAATGAAGAGTATTCGTGCTGCTTTTCATAGAATAAATGATAATTTGACATAGACATAGATATAAGTTCCA GCTCTGAAATTAATTAGGAAAGAATATAGGATGTTTACAGTGAATAATTTTAAAACCACAAACATAGCAGAAATGTACTTTATTATTAAA TTTGTAATGCAGGATTAGAAGAAGCAGAGCTCTAGTTTAGCCTTTCTTGTCTCACAGATGTGCTGTATCCCAGGCATACTATAAAACGAA GAGTGCCCAACCAAGCTTTGAATCGTATTAACAATGCCCACCTCTATGCTAGCTGAGGATAAATTTACCAGTTGCTCATATTTAAACTGA CCTAAATATGTTTTGCTGAGCATAAGATAAACTCACTTTTACCTCCATCTAAAATTATCCTGTTCTGATGCCAATTCAATTTCAGCTCTG CAAGTTCTTGTCAGGCTAATCTTTAAACATTGAGTGATCTTGAGAGATTGTTAATGAAAGCAGTGAGTCATTTTTTGATGATTGATTTGT TGGAAAAATGTTGATGTGTTTTAAAAAATGTAATCTTCAAAAACAGAATATAACCTGAGATGCATTTGTAGAGACAAGACGGTACGAGAA TGTGTGTGTGTGTGTGTGTGAGAGAGAGAGACTTTTGATGAAGAACTAAATCTTGGATTGCTGATAGCAAAGATCATAGTGCTGTTGGAA TATCAGCAATATAGAGTTATTCTTAAACACATTCTATTAACATGTTTTTGTCATTGGGTCCAAAAATTTTGCTGCTGACCAGAATTTACT ATTTGTTACCTATATTCTTTTTTTTTTTTTTTTTTTTTTTTTTTGAGACAGAGTCTTGCTCTGTCGCCCAGGCTGGAATGCAGTGGTGTG ATCTCGGCTCACTGCTACCTCCACCTCCTGGATTCAAGTGATTCTCCTGCCTCAGCCTCCCGAGTAGCTGGGATTACAGGAATGCGCCAC AACGCCCAGCTAATTTGTTACCTACACTCTAATTAATAATTAATAATTTCTTATTTTAAAAAGTAGTACTATTTAATATAATCAAGATAG GAGATTTAAAATGAGCAAGTGATTCATTTGCTCTTTTAAAGAAGCCCGTTGACTTACGCTTTTAAAAAAGAAGTTGGTGGGTTACCTCAA TTATTGTTCATGCTTAAACATATCCATTTGTACAGGCTTATTTCTACGTGGGACCCAATCATATATACTATATTTCTCAAATAATTTTTC TAAAACTCTGGCCTATATTCTAAACACTTGACCAACACCTTAGTTATTGAATAGGTAACCATTTTTAAAGTACATGTGGTTCATTTTTTA AAATTCAATCTCTCAAGACCGTTAGATATTTAATAATTTAAGCTGATAAGGGTATCAAAATGCACATTAACTTTGATCATCATGATTTAA GTTGTAACTTTGTGTTATTATATAAATATTAGGTTGTTTATAAATATATTGCAGAAAGTATTCTTGTTAAGCTCTTTTAAATGAGGGGAC TGTGGTTTAGAGTTATATATTTTTGCTTATTTTTAAACTTCAATTATTCCATTCTTCTGCCTTATAATAAAACTTTTAAGGCAGAGAACT GAACTAATTATAGAATTTCTCCTTTGGAGAGTTATAATGTTACATAGTGAACATTCTTATAAAAGAAAGAATAAGTTTAAGTTGATGAAT ATTTAGCTGCAAAGATTTTTTACTTAAAAAAATCCATGAATATCTTTGATTTTATTATAAAGCATTTGTAAATTATTTGCATTTGAGCTG TAAGATTCATAAACATTTACATTTCCCAATGATTTCTATTTTGATTTTTAAAAAATATACAGGGCAAGCTACATTTTTAAAGCATTAATC AACAACTTTATTATATTACACATTCCAGTGCACAAACACACAATATCATTTAATACTCACAGTAGTACCTGTGAAATATATCAGATGGAT ATTCCTATCTCTATTTTACAGCAGAGGAAACCGAAATTCAGAGAACTTACATTTCTAAGGTTGTACAGCTGCAAAATGACCAAATTGTGA AGTCCCTAACATCCAGGTTTTCATAATGCCAGTACTCTTTCTATGACATGTTTATGACCCTCCAAATGTACCAAAACTACCTAACTAATT CACTGAGAGGAAGCCAACTGCAAAAATAGGATTTTTAAAAGTACAATAGAGTATTACTACATTTTATGGATTTCAGACAAAGAAACCTCC GTTTATTATATCCTGATGGTGAGTATTGCCAGCTCTAAATTATTCATATTTCTAAGACCAAGGAAAATATAGGTAAATGAAAATTTTGAA ATAAAGAACAATGCCTTAATTTGTAAAATCTATCATTGCTACCACCCTGCCCAGGTCTGGCCATTTGCCATAAATGCTGGTAAATAAATA >68924_68924_1_PRMT2-SLC41A2_PRMT2_chr21_48069651_ENST00000291705_SLC41A2_chr12_105199115_ENST00000258538_length(amino acids)=279AA_BP=218 MATSGDCPRSESQGEEPAECSEAGLLQEGVQPEEFVAIADYAATDETQLSFLRGEKILILRQTTADWWWGERAGCCGYIPANHVGKHVDE YDPEDTWQDEEYFGSYGTLKLHLEMLADQPRTTKYHSVILQNKESLTDKVILDVGCGTGIISLFCAHYARPRAVYAVEASEMAQHTGQLV LQNGFADIITVYQQKVEDVVLPEKVDVLVSEWMGTCLLVFTLLWIADWMVHHFWRKGKDPDSFSIPYLTALGDLLGTALLALSFHFLWLI -------------------------------------------------------------- >68924_68924_2_PRMT2-SLC41A2_PRMT2_chr21_48069651_ENST00000334494_SLC41A2_chr12_105199115_ENST00000258538_length(transcript)=3606nt_BP=821nt TGCACTGCGCTTGCGCGGGTTGAGGGCGGTGGCTCAGGCTCCTGGAAAGGACCGTCCACCCCTCCGCGCTGGCGGTGTGGACGCGGAACT CAGCGGAGAAACGCGATTGAGAAATGGAAAAGAAAATGAAATAAATCAGCAGTTATGAGGCAGAGCCTAAGAGAACTATGGCAACATCAG GTGACTGTCCCAGAAGTGAATCGCAGGGAGAAGAGCCTGCTGAGTGCAGTGAGGCCGGTCTCCTGCAGGAGGGAGTACAGCCAGAGGAGT TTGTGGCCATCGCGGACTACGCTGCCACCGATGAGACCCAGCTCAGTTTTTTGAGAGGAGAAAAAATTCTTATCCTGAGACAAACCACTG CAGATTGGTGGTGGGGTGAGCGTGCGGGCTGCTGTGGGTACATTCCGGCAAACCATGTGGGGAAGCACGTGGATGAGTACGACCCCGAGG ACACGTGGCAGGATGAAGAGTACTTCGGCAGCTATGGAACTCTGAAACTCCACTTGGAGATGTTGGCAGACCAGCCACGAACAACTAAAT ACCACAGTGTCATCCTGCAGAATAAAGAATCCCTGACGGATAAAGTCATCCTGGACGTGGGCTGTGGGACTGGGATCATCAGTCTCTTCT GTGCACACTATGCGCGGCCTAGAGCGGTGTACGCGGTGGAGGCCAGTGAGATGGCACAGCACACGGGGCAGCTGGTCCTGCAGAACGGCT TTGCTGACATCATCACCGTGTACCAGCAGAAGGTGGAGGATGTGGTGCTGCCCGAGAAGGTGGACGTGCTGGTGTCTGAGTGGATGGGGA CCTGCCTGCTGGTATTTACCTTGCTGTGGATTGCTGACTGGATGGTCCATCACTTCTGGAGGAAAGGAAAGGACCCGGATAGTTTCTCCA TCCCCTACCTAACAGCATTGGGTGATCTGCTCGGGACAGCTCTGTTAGCCTTAAGTTTTCATTTTCTTTGGCTTATTGGAGATCGAGATG GAGATGTTGGAGACTAATAAATTCTACAAACTGCTCTCAAGTTACCAAGGAAGAAAATACACGACAACCACTTATGGCTCTTTTTCAAAA CTCTTAAATCAGTAGTTTGACTTTTGCCAGGGTAATCTTCAGTTGGCCCTGATTCAATTAAATGGCCTTAATTTTTTTTTAAGGAATTTG TGTCAAAACCAGAATGAAGAGTATTCGTGCTGCTTTTCATAGAATAAATGATAATTTGACATAGACATAGATATAAGTTCCAGCTCTGAA ATTAATTAGGAAAGAATATAGGATGTTTACAGTGAATAATTTTAAAACCACAAACATAGCAGAAATGTACTTTATTATTAAATTTGTAAT GCAGGATTAGAAGAAGCAGAGCTCTAGTTTAGCCTTTCTTGTCTCACAGATGTGCTGTATCCCAGGCATACTATAAAACGAAGAGTGCCC AACCAAGCTTTGAATCGTATTAACAATGCCCACCTCTATGCTAGCTGAGGATAAATTTACCAGTTGCTCATATTTAAACTGACCTAAATA TGTTTTGCTGAGCATAAGATAAACTCACTTTTACCTCCATCTAAAATTATCCTGTTCTGATGCCAATTCAATTTCAGCTCTGCAAGTTCT TGTCAGGCTAATCTTTAAACATTGAGTGATCTTGAGAGATTGTTAATGAAAGCAGTGAGTCATTTTTTGATGATTGATTTGTTGGAAAAA TGTTGATGTGTTTTAAAAAATGTAATCTTCAAAAACAGAATATAACCTGAGATGCATTTGTAGAGACAAGACGGTACGAGAATGTGTGTG TGTGTGTGTGTGAGAGAGAGAGACTTTTGATGAAGAACTAAATCTTGGATTGCTGATAGCAAAGATCATAGTGCTGTTGGAATATCAGCA ATATAGAGTTATTCTTAAACACATTCTATTAACATGTTTTTGTCATTGGGTCCAAAAATTTTGCTGCTGACCAGAATTTACTATTTGTTA CCTATATTCTTTTTTTTTTTTTTTTTTTTTTTTTTTGAGACAGAGTCTTGCTCTGTCGCCCAGGCTGGAATGCAGTGGTGTGATCTCGGC TCACTGCTACCTCCACCTCCTGGATTCAAGTGATTCTCCTGCCTCAGCCTCCCGAGTAGCTGGGATTACAGGAATGCGCCACAACGCCCA GCTAATTTGTTACCTACACTCTAATTAATAATTAATAATTTCTTATTTTAAAAAGTAGTACTATTTAATATAATCAAGATAGGAGATTTA AAATGAGCAAGTGATTCATTTGCTCTTTTAAAGAAGCCCGTTGACTTACGCTTTTAAAAAAGAAGTTGGTGGGTTACCTCAATTATTGTT CATGCTTAAACATATCCATTTGTACAGGCTTATTTCTACGTGGGACCCAATCATATATACTATATTTCTCAAATAATTTTTCTAAAACTC TGGCCTATATTCTAAACACTTGACCAACACCTTAGTTATTGAATAGGTAACCATTTTTAAAGTACATGTGGTTCATTTTTTAAAATTCAA TCTCTCAAGACCGTTAGATATTTAATAATTTAAGCTGATAAGGGTATCAAAATGCACATTAACTTTGATCATCATGATTTAAGTTGTAAC TTTGTGTTATTATATAAATATTAGGTTGTTTATAAATATATTGCAGAAAGTATTCTTGTTAAGCTCTTTTAAATGAGGGGACTGTGGTTT AGAGTTATATATTTTTGCTTATTTTTAAACTTCAATTATTCCATTCTTCTGCCTTATAATAAAACTTTTAAGGCAGAGAACTGAACTAAT TATAGAATTTCTCCTTTGGAGAGTTATAATGTTACATAGTGAACATTCTTATAAAAGAAAGAATAAGTTTAAGTTGATGAATATTTAGCT GCAAAGATTTTTTACTTAAAAAAATCCATGAATATCTTTGATTTTATTATAAAGCATTTGTAAATTATTTGCATTTGAGCTGTAAGATTC ATAAACATTTACATTTCCCAATGATTTCTATTTTGATTTTTAAAAAATATACAGGGCAAGCTACATTTTTAAAGCATTAATCAACAACTT TATTATATTACACATTCCAGTGCACAAACACACAATATCATTTAATACTCACAGTAGTACCTGTGAAATATATCAGATGGATATTCCTAT CTCTATTTTACAGCAGAGGAAACCGAAATTCAGAGAACTTACATTTCTAAGGTTGTACAGCTGCAAAATGACCAAATTGTGAAGTCCCTA ACATCCAGGTTTTCATAATGCCAGTACTCTTTCTATGACATGTTTATGACCCTCCAAATGTACCAAAACTACCTAACTAATTCACTGAGA GGAAGCCAACTGCAAAAATAGGATTTTTAAAAGTACAATAGAGTATTACTACATTTTATGGATTTCAGACAAAGAAACCTCCGTTTATTA TATCCTGATGGTGAGTATTGCCAGCTCTAAATTATTCATATTTCTAAGACCAAGGAAAATATAGGTAAATGAAAATTTTGAAATAAAGAA CAATGCCTTAATTTGTAAAATCTATCATTGCTACCACCCTGCCCAGGTCTGGCCATTTGCCATAAATGCTGGTAAATAAATACAATGACT >68924_68924_2_PRMT2-SLC41A2_PRMT2_chr21_48069651_ENST00000334494_SLC41A2_chr12_105199115_ENST00000258538_length(amino acids)=279AA_BP=218 MATSGDCPRSESQGEEPAECSEAGLLQEGVQPEEFVAIADYAATDETQLSFLRGEKILILRQTTADWWWGERAGCCGYIPANHVGKHVDE YDPEDTWQDEEYFGSYGTLKLHLEMLADQPRTTKYHSVILQNKESLTDKVILDVGCGTGIISLFCAHYARPRAVYAVEASEMAQHTGQLV LQNGFADIITVYQQKVEDVVLPEKVDVLVSEWMGTCLLVFTLLWIADWMVHHFWRKGKDPDSFSIPYLTALGDLLGTALLALSFHFLWLI -------------------------------------------------------------- >68924_68924_3_PRMT2-SLC41A2_PRMT2_chr21_48069651_ENST00000355680_SLC41A2_chr12_105199115_ENST00000258538_length(transcript)=4201nt_BP=1416nt ACTTATCCAGAAGAAAGGCAGAGGGCGCACACTGCGCAGCGCGGATGGGAAAGTTAACTGAATTATTTGCGGGAAGACAGAGGAGGTGGG GGGTCCCCCAAGCCCCAGCCATTTTGTGGCTCGTAGGGGTTGTCGCTTCCCAAGCCGTGAATGGCCCAAACCCGCCCCCCGCCCCAGGTC GGACTCCTGCCCCGCGCCCCTCTGGGTCGGACCCCAAGCCGAGCCCCCCAACCCCGCGGCTGGGCTGGGCGATTGGGGACGAGCTCCACA CATGGAGAACCTGGCCTCGCCTCGCAAGACCGCGGGACGCGCAGATGTGAAGTGCGCCTGCGCGGGGCGCAGCCCCAGCTGCAGACGATC TGTGAGCGACGCGCCGGCGCAAGTCGAGGGCGGTGGCTTGGCTTCCCTGGAATGGGGGACGTCTTAGGACTGCGCCTGCGCGGGGCGCCG GGCCCTGGGCGGGGCCTTCCCGGCTGACGGCCTGCGTGCACTGCGCTTGCGCGGGTTGAGGGCGGTGGCTCAGGCTCCTGGAAAGGACCG TCCACCCCTCCGCGCTGGCGGTGTGGACGCGGAACTCAGCGGAGAAACGCGATTGAGAGCAGTGTGTGGATTACACTATCACTGGAAAAA TACGAATTGAGAAGAAGGAAAAGACTGGAAGATGCAGACCTTGGTTCCTGTTAGTGGAAACACTGTAAGGTCCCAGAAATGGAAAAGAAA ATGAAATAAATCAGCAGTTATGAGGCAGAGCCTAAGAGAACTATGGCAACATCAGGTGACTGTCCCAGAAGTGAATCGCAGGGAGAAGAG CCTGCTGAGTGCAGTGAGGCCGGTCTCCTGCAGGAGGGAGTACAGCCAGAGGAGTTTGTGGCCATCGCGGACTACGCTGCCACCGATGAG ACCCAGCTCAGTTTTTTGAGAGGAGAAAAAATTCTTATCCTGAGACAAACCACTGCAGATTGGTGGTGGGGTGAGCGTGCGGGCTGCTGT GGGTACATTCCGGCAAACCATGTGGGGAAGCACGTGGATGAGTACGACCCCGAGGACACGTGGCAGGATGAAGAGTACTTCGGCAGCTAT GGAACTCTGAAACTCCACTTGGAGATGTTGGCAGACCAGCCACGAACAACTAAATACCACAGTGTCATCCTGCAGAATAAAGAATCCCTG ACGGATAAAGTCATCCTGGACGTGGGCTGTGGGACTGGGATCATCAGTCTCTTCTGTGCACACTATGCGCGGCCTAGAGCGGTGTACGCG GTGGAGGCCAGTGAGATGGCACAGCACACGGGGCAGCTGGTCCTGCAGAACGGCTTTGCTGACATCATCACCGTGTACCAGCAGAAGGTG GAGGATGTGGTGCTGCCCGAGAAGGTGGACGTGCTGGTGTCTGAGTGGATGGGGACCTGCCTGCTGGTATTTACCTTGCTGTGGATTGCT GACTGGATGGTCCATCACTTCTGGAGGAAAGGAAAGGACCCGGATAGTTTCTCCATCCCCTACCTAACAGCATTGGGTGATCTGCTCGGG ACAGCTCTGTTAGCCTTAAGTTTTCATTTTCTTTGGCTTATTGGAGATCGAGATGGAGATGTTGGAGACTAATAAATTCTACAAACTGCT CTCAAGTTACCAAGGAAGAAAATACACGACAACCACTTATGGCTCTTTTTCAAAACTCTTAAATCAGTAGTTTGACTTTTGCCAGGGTAA TCTTCAGTTGGCCCTGATTCAATTAAATGGCCTTAATTTTTTTTTAAGGAATTTGTGTCAAAACCAGAATGAAGAGTATTCGTGCTGCTT TTCATAGAATAAATGATAATTTGACATAGACATAGATATAAGTTCCAGCTCTGAAATTAATTAGGAAAGAATATAGGATGTTTACAGTGA ATAATTTTAAAACCACAAACATAGCAGAAATGTACTTTATTATTAAATTTGTAATGCAGGATTAGAAGAAGCAGAGCTCTAGTTTAGCCT TTCTTGTCTCACAGATGTGCTGTATCCCAGGCATACTATAAAACGAAGAGTGCCCAACCAAGCTTTGAATCGTATTAACAATGCCCACCT CTATGCTAGCTGAGGATAAATTTACCAGTTGCTCATATTTAAACTGACCTAAATATGTTTTGCTGAGCATAAGATAAACTCACTTTTACC TCCATCTAAAATTATCCTGTTCTGATGCCAATTCAATTTCAGCTCTGCAAGTTCTTGTCAGGCTAATCTTTAAACATTGAGTGATCTTGA GAGATTGTTAATGAAAGCAGTGAGTCATTTTTTGATGATTGATTTGTTGGAAAAATGTTGATGTGTTTTAAAAAATGTAATCTTCAAAAA CAGAATATAACCTGAGATGCATTTGTAGAGACAAGACGGTACGAGAATGTGTGTGTGTGTGTGTGTGAGAGAGAGAGACTTTTGATGAAG AACTAAATCTTGGATTGCTGATAGCAAAGATCATAGTGCTGTTGGAATATCAGCAATATAGAGTTATTCTTAAACACATTCTATTAACAT GTTTTTGTCATTGGGTCCAAAAATTTTGCTGCTGACCAGAATTTACTATTTGTTACCTATATTCTTTTTTTTTTTTTTTTTTTTTTTTTT TGAGACAGAGTCTTGCTCTGTCGCCCAGGCTGGAATGCAGTGGTGTGATCTCGGCTCACTGCTACCTCCACCTCCTGGATTCAAGTGATT CTCCTGCCTCAGCCTCCCGAGTAGCTGGGATTACAGGAATGCGCCACAACGCCCAGCTAATTTGTTACCTACACTCTAATTAATAATTAA TAATTTCTTATTTTAAAAAGTAGTACTATTTAATATAATCAAGATAGGAGATTTAAAATGAGCAAGTGATTCATTTGCTCTTTTAAAGAA GCCCGTTGACTTACGCTTTTAAAAAAGAAGTTGGTGGGTTACCTCAATTATTGTTCATGCTTAAACATATCCATTTGTACAGGCTTATTT CTACGTGGGACCCAATCATATATACTATATTTCTCAAATAATTTTTCTAAAACTCTGGCCTATATTCTAAACACTTGACCAACACCTTAG TTATTGAATAGGTAACCATTTTTAAAGTACATGTGGTTCATTTTTTAAAATTCAATCTCTCAAGACCGTTAGATATTTAATAATTTAAGC TGATAAGGGTATCAAAATGCACATTAACTTTGATCATCATGATTTAAGTTGTAACTTTGTGTTATTATATAAATATTAGGTTGTTTATAA ATATATTGCAGAAAGTATTCTTGTTAAGCTCTTTTAAATGAGGGGACTGTGGTTTAGAGTTATATATTTTTGCTTATTTTTAAACTTCAA TTATTCCATTCTTCTGCCTTATAATAAAACTTTTAAGGCAGAGAACTGAACTAATTATAGAATTTCTCCTTTGGAGAGTTATAATGTTAC ATAGTGAACATTCTTATAAAAGAAAGAATAAGTTTAAGTTGATGAATATTTAGCTGCAAAGATTTTTTACTTAAAAAAATCCATGAATAT CTTTGATTTTATTATAAAGCATTTGTAAATTATTTGCATTTGAGCTGTAAGATTCATAAACATTTACATTTCCCAATGATTTCTATTTTG ATTTTTAAAAAATATACAGGGCAAGCTACATTTTTAAAGCATTAATCAACAACTTTATTATATTACACATTCCAGTGCACAAACACACAA TATCATTTAATACTCACAGTAGTACCTGTGAAATATATCAGATGGATATTCCTATCTCTATTTTACAGCAGAGGAAACCGAAATTCAGAG AACTTACATTTCTAAGGTTGTACAGCTGCAAAATGACCAAATTGTGAAGTCCCTAACATCCAGGTTTTCATAATGCCAGTACTCTTTCTA TGACATGTTTATGACCCTCCAAATGTACCAAAACTACCTAACTAATTCACTGAGAGGAAGCCAACTGCAAAAATAGGATTTTTAAAAGTA CAATAGAGTATTACTACATTTTATGGATTTCAGACAAAGAAACCTCCGTTTATTATATCCTGATGGTGAGTATTGCCAGCTCTAAATTAT TCATATTTCTAAGACCAAGGAAAATATAGGTAAATGAAAATTTTGAAATAAAGAACAATGCCTTAATTTGTAAAATCTATCATTGCTACC >68924_68924_3_PRMT2-SLC41A2_PRMT2_chr21_48069651_ENST00000355680_SLC41A2_chr12_105199115_ENST00000258538_length(amino acids)=279AA_BP=218 MATSGDCPRSESQGEEPAECSEAGLLQEGVQPEEFVAIADYAATDETQLSFLRGEKILILRQTTADWWWGERAGCCGYIPANHVGKHVDE YDPEDTWQDEEYFGSYGTLKLHLEMLADQPRTTKYHSVILQNKESLTDKVILDVGCGTGIISLFCAHYARPRAVYAVEASEMAQHTGQLV LQNGFADIITVYQQKVEDVVLPEKVDVLVSEWMGTCLLVFTLLWIADWMVHHFWRKGKDPDSFSIPYLTALGDLLGTALLALSFHFLWLI -------------------------------------------------------------- >68924_68924_4_PRMT2-SLC41A2_PRMT2_chr21_48069651_ENST00000397637_SLC41A2_chr12_105199115_ENST00000258538_length(transcript)=4393nt_BP=1608nt GCGTGCACTGCGCTTGCGCGGGTTGAGGGCGGTGGCTCAGGCTCCTGGAAAGGACCGTCCACCCCTCCGCGCTGGCGGTGTGGACGCGGA ACTCAGCGGAGAAACGCGATTGAGGTAGGTGTCCTGATGGGCAGCTCAGATGGCTGGACTGCACGTAAGGAAGGACAGGCCAGGTGAGGC GTCCTCGCACTGCGTGTGCGTCGCTGGCGGACAGAGGCCTCCGCCCCCTTTTGGGACCTCCGAGCGCCTTCGCGATCTCAGCCACTTTCC CTGGCGTCCAAACGGGAGCTCGGTCCCCGTCACACCCTTCCCTGCGTGCCGCACCCCTTCCCGGCCACTCCCGCCGTCCAGCGCCTTCTA CGGCCACGCCCACCCCACCACCATCTCTGTCACGCCCTTCGCGGCCACGCCCACCTGCCTGGCGGCCCCTGCCCCGAAGCTCGCGGCGCT GTCCCAGCCTGACCCTCTCGTGCCCCTGCGTCCACGCGTGGCCCTCTCGCTTCCTGCCCCCTTCTCACCCCCCTTCACTGGCCACCTGTT CCAACCCTCCATGATCCTGTTCCTCCCGAGGGCATCTTAGGAGGGCAGGGTCCTGCGCGCACTGCGGCCTCCACTCCGACCCCGTCCCAG TTTGGACCCAGGTCTTCCAATGAAAATATAATTATGCAAATCAGTAAGCATTTGTAACTACGAATATCACAAAAATAAGCTTCAAGTCTG GATTTAGAAGTGAAGCATGCATTTTAAACAAAGAATTGCTATGCAATTTTAAAAACACATTGATCCCAGAGCAGTGTGTGGATTACACTA TCACTGGAAAAATACGAATTGAGAAGAAGGAAAAGACTGGAAGATGCAGACCTTGGTTCCTGTTAGTGGAAACACTGTAAGGTCCCAGAA ATGGAAAAGAAAATGAAATAAATCAGCAGTTATGAGGCAGAGCCTAAGAGAACTATGGCAACATCAGGTGACTGTCCCAGAAGTGAATCG CAGGGAGAAGAGCCTGCTGAGTGCAGTGAGGCCGGTCTCCTGCAGGAGGGAGTACAGCCAGAGGAGTTTGTGGCCATCGCGGACTACGCT GCCACCGATGAGACCCAGCTCAGTTTTTTGAGAGGAGAAAAAATTCTTATCCTGAGACAAACCACTGCAGATTGGTGGTGGGGTGAGCGT GCGGGCTGCTGTGGGTACATTCCGGCAAACCATGTGGGGAAGCACGTGGATGAGTACGACCCCGAGGACACGTGGCAGGATGAAGAGTAC TTCGGCAGCTATGGAACTCTGAAACTCCACTTGGAGATGTTGGCAGACCAGCCACGAACAACTAAATACCACAGTGTCATCCTGCAGAAT AAAGAATCCCTGACGGATAAAGTCATCCTGGACGTGGGCTGTGGGACTGGGATCATCAGTCTCTTCTGTGCACACTATGCGCGGCCTAGA GCGGTGTACGCGGTGGAGGCCAGTGAGATGGCACAGCACACGGGGCAGCTGGTCCTGCAGAACGGCTTTGCTGACATCATCACCGTGTAC CAGCAGAAGGTGGAGGATGTGGTGCTGCCCGAGAAGGTGGACGTGCTGGTGTCTGAGTGGATGGGGACCTGCCTGCTGGTATTTACCTTG CTGTGGATTGCTGACTGGATGGTCCATCACTTCTGGAGGAAAGGAAAGGACCCGGATAGTTTCTCCATCCCCTACCTAACAGCATTGGGT GATCTGCTCGGGACAGCTCTGTTAGCCTTAAGTTTTCATTTTCTTTGGCTTATTGGAGATCGAGATGGAGATGTTGGAGACTAATAAATT CTACAAACTGCTCTCAAGTTACCAAGGAAGAAAATACACGACAACCACTTATGGCTCTTTTTCAAAACTCTTAAATCAGTAGTTTGACTT TTGCCAGGGTAATCTTCAGTTGGCCCTGATTCAATTAAATGGCCTTAATTTTTTTTTAAGGAATTTGTGTCAAAACCAGAATGAAGAGTA TTCGTGCTGCTTTTCATAGAATAAATGATAATTTGACATAGACATAGATATAAGTTCCAGCTCTGAAATTAATTAGGAAAGAATATAGGA TGTTTACAGTGAATAATTTTAAAACCACAAACATAGCAGAAATGTACTTTATTATTAAATTTGTAATGCAGGATTAGAAGAAGCAGAGCT CTAGTTTAGCCTTTCTTGTCTCACAGATGTGCTGTATCCCAGGCATACTATAAAACGAAGAGTGCCCAACCAAGCTTTGAATCGTATTAA CAATGCCCACCTCTATGCTAGCTGAGGATAAATTTACCAGTTGCTCATATTTAAACTGACCTAAATATGTTTTGCTGAGCATAAGATAAA CTCACTTTTACCTCCATCTAAAATTATCCTGTTCTGATGCCAATTCAATTTCAGCTCTGCAAGTTCTTGTCAGGCTAATCTTTAAACATT GAGTGATCTTGAGAGATTGTTAATGAAAGCAGTGAGTCATTTTTTGATGATTGATTTGTTGGAAAAATGTTGATGTGTTTTAAAAAATGT AATCTTCAAAAACAGAATATAACCTGAGATGCATTTGTAGAGACAAGACGGTACGAGAATGTGTGTGTGTGTGTGTGTGAGAGAGAGAGA CTTTTGATGAAGAACTAAATCTTGGATTGCTGATAGCAAAGATCATAGTGCTGTTGGAATATCAGCAATATAGAGTTATTCTTAAACACA TTCTATTAACATGTTTTTGTCATTGGGTCCAAAAATTTTGCTGCTGACCAGAATTTACTATTTGTTACCTATATTCTTTTTTTTTTTTTT TTTTTTTTTTTTTGAGACAGAGTCTTGCTCTGTCGCCCAGGCTGGAATGCAGTGGTGTGATCTCGGCTCACTGCTACCTCCACCTCCTGG ATTCAAGTGATTCTCCTGCCTCAGCCTCCCGAGTAGCTGGGATTACAGGAATGCGCCACAACGCCCAGCTAATTTGTTACCTACACTCTA ATTAATAATTAATAATTTCTTATTTTAAAAAGTAGTACTATTTAATATAATCAAGATAGGAGATTTAAAATGAGCAAGTGATTCATTTGC TCTTTTAAAGAAGCCCGTTGACTTACGCTTTTAAAAAAGAAGTTGGTGGGTTACCTCAATTATTGTTCATGCTTAAACATATCCATTTGT ACAGGCTTATTTCTACGTGGGACCCAATCATATATACTATATTTCTCAAATAATTTTTCTAAAACTCTGGCCTATATTCTAAACACTTGA CCAACACCTTAGTTATTGAATAGGTAACCATTTTTAAAGTACATGTGGTTCATTTTTTAAAATTCAATCTCTCAAGACCGTTAGATATTT AATAATTTAAGCTGATAAGGGTATCAAAATGCACATTAACTTTGATCATCATGATTTAAGTTGTAACTTTGTGTTATTATATAAATATTA GGTTGTTTATAAATATATTGCAGAAAGTATTCTTGTTAAGCTCTTTTAAATGAGGGGACTGTGGTTTAGAGTTATATATTTTTGCTTATT TTTAAACTTCAATTATTCCATTCTTCTGCCTTATAATAAAACTTTTAAGGCAGAGAACTGAACTAATTATAGAATTTCTCCTTTGGAGAG TTATAATGTTACATAGTGAACATTCTTATAAAAGAAAGAATAAGTTTAAGTTGATGAATATTTAGCTGCAAAGATTTTTTACTTAAAAAA ATCCATGAATATCTTTGATTTTATTATAAAGCATTTGTAAATTATTTGCATTTGAGCTGTAAGATTCATAAACATTTACATTTCCCAATG ATTTCTATTTTGATTTTTAAAAAATATACAGGGCAAGCTACATTTTTAAAGCATTAATCAACAACTTTATTATATTACACATTCCAGTGC ACAAACACACAATATCATTTAATACTCACAGTAGTACCTGTGAAATATATCAGATGGATATTCCTATCTCTATTTTACAGCAGAGGAAAC CGAAATTCAGAGAACTTACATTTCTAAGGTTGTACAGCTGCAAAATGACCAAATTGTGAAGTCCCTAACATCCAGGTTTTCATAATGCCA GTACTCTTTCTATGACATGTTTATGACCCTCCAAATGTACCAAAACTACCTAACTAATTCACTGAGAGGAAGCCAACTGCAAAAATAGGA TTTTTAAAAGTACAATAGAGTATTACTACATTTTATGGATTTCAGACAAAGAAACCTCCGTTTATTATATCCTGATGGTGAGTATTGCCA GCTCTAAATTATTCATATTTCTAAGACCAAGGAAAATATAGGTAAATGAAAATTTTGAAATAAAGAACAATGCCTTAATTTGTAAAATCT >68924_68924_4_PRMT2-SLC41A2_PRMT2_chr21_48069651_ENST00000397637_SLC41A2_chr12_105199115_ENST00000258538_length(amino acids)=279AA_BP=218 MATSGDCPRSESQGEEPAECSEAGLLQEGVQPEEFVAIADYAATDETQLSFLRGEKILILRQTTADWWWGERAGCCGYIPANHVGKHVDE YDPEDTWQDEEYFGSYGTLKLHLEMLADQPRTTKYHSVILQNKESLTDKVILDVGCGTGIISLFCAHYARPRAVYAVEASEMAQHTGQLV LQNGFADIITVYQQKVEDVVLPEKVDVLVSEWMGTCLLVFTLLWIADWMVHHFWRKGKDPDSFSIPYLTALGDLLGTALLALSFHFLWLI -------------------------------------------------------------- >68924_68924_5_PRMT2-SLC41A2_PRMT2_chr21_48069651_ENST00000397638_SLC41A2_chr12_105199115_ENST00000258538_length(transcript)=3644nt_BP=859nt CGGGCCCTGGGCGGGGCCTTCCCGGCTGACGGCCTGCGTGCACTGCGCTTGCGCGGGTTGAGGGCGGTGGCTCAGGCTCCTGGAAAGGAC CGTCCACCCCTCCGCGCTGGCGGTGTGGACGCGGAACTCAGCGGAGAAACGCGATTGAGAAATGGAAAAGAAAATGAAATAAATCAGCAG TTATGAGGCAGAGCCTAAGAGAACTATGGCAACATCAGGTGACTGTCCCAGAAGTGAATCGCAGGGAGAAGAGCCTGCTGAGTGCAGTGA GGCCGGTCTCCTGCAGGAGGGAGTACAGCCAGAGGAGTTTGTGGCCATCGCGGACTACGCTGCCACCGATGAGACCCAGCTCAGTTTTTT GAGAGGAGAAAAAATTCTTATCCTGAGACAAACCACTGCAGATTGGTGGTGGGGTGAGCGTGCGGGCTGCTGTGGGTACATTCCGGCAAA CCATGTGGGGAAGCACGTGGATGAGTACGACCCCGAGGACACGTGGCAGGATGAAGAGTACTTCGGCAGCTATGGAACTCTGAAACTCCA CTTGGAGATGTTGGCAGACCAGCCACGAACAACTAAATACCACAGTGTCATCCTGCAGAATAAAGAATCCCTGACGGATAAAGTCATCCT GGACGTGGGCTGTGGGACTGGGATCATCAGTCTCTTCTGTGCACACTATGCGCGGCCTAGAGCGGTGTACGCGGTGGAGGCCAGTGAGAT GGCACAGCACACGGGGCAGCTGGTCCTGCAGAACGGCTTTGCTGACATCATCACCGTGTACCAGCAGAAGGTGGAGGATGTGGTGCTGCC CGAGAAGGTGGACGTGCTGGTGTCTGAGTGGATGGGGACCTGCCTGCTGGTATTTACCTTGCTGTGGATTGCTGACTGGATGGTCCATCA CTTCTGGAGGAAAGGAAAGGACCCGGATAGTTTCTCCATCCCCTACCTAACAGCATTGGGTGATCTGCTCGGGACAGCTCTGTTAGCCTT AAGTTTTCATTTTCTTTGGCTTATTGGAGATCGAGATGGAGATGTTGGAGACTAATAAATTCTACAAACTGCTCTCAAGTTACCAAGGAA GAAAATACACGACAACCACTTATGGCTCTTTTTCAAAACTCTTAAATCAGTAGTTTGACTTTTGCCAGGGTAATCTTCAGTTGGCCCTGA TTCAATTAAATGGCCTTAATTTTTTTTTAAGGAATTTGTGTCAAAACCAGAATGAAGAGTATTCGTGCTGCTTTTCATAGAATAAATGAT AATTTGACATAGACATAGATATAAGTTCCAGCTCTGAAATTAATTAGGAAAGAATATAGGATGTTTACAGTGAATAATTTTAAAACCACA AACATAGCAGAAATGTACTTTATTATTAAATTTGTAATGCAGGATTAGAAGAAGCAGAGCTCTAGTTTAGCCTTTCTTGTCTCACAGATG TGCTGTATCCCAGGCATACTATAAAACGAAGAGTGCCCAACCAAGCTTTGAATCGTATTAACAATGCCCACCTCTATGCTAGCTGAGGAT AAATTTACCAGTTGCTCATATTTAAACTGACCTAAATATGTTTTGCTGAGCATAAGATAAACTCACTTTTACCTCCATCTAAAATTATCC TGTTCTGATGCCAATTCAATTTCAGCTCTGCAAGTTCTTGTCAGGCTAATCTTTAAACATTGAGTGATCTTGAGAGATTGTTAATGAAAG CAGTGAGTCATTTTTTGATGATTGATTTGTTGGAAAAATGTTGATGTGTTTTAAAAAATGTAATCTTCAAAAACAGAATATAACCTGAGA TGCATTTGTAGAGACAAGACGGTACGAGAATGTGTGTGTGTGTGTGTGTGAGAGAGAGAGACTTTTGATGAAGAACTAAATCTTGGATTG CTGATAGCAAAGATCATAGTGCTGTTGGAATATCAGCAATATAGAGTTATTCTTAAACACATTCTATTAACATGTTTTTGTCATTGGGTC CAAAAATTTTGCTGCTGACCAGAATTTACTATTTGTTACCTATATTCTTTTTTTTTTTTTTTTTTTTTTTTTTTGAGACAGAGTCTTGCT CTGTCGCCCAGGCTGGAATGCAGTGGTGTGATCTCGGCTCACTGCTACCTCCACCTCCTGGATTCAAGTGATTCTCCTGCCTCAGCCTCC CGAGTAGCTGGGATTACAGGAATGCGCCACAACGCCCAGCTAATTTGTTACCTACACTCTAATTAATAATTAATAATTTCTTATTTTAAA AAGTAGTACTATTTAATATAATCAAGATAGGAGATTTAAAATGAGCAAGTGATTCATTTGCTCTTTTAAAGAAGCCCGTTGACTTACGCT TTTAAAAAAGAAGTTGGTGGGTTACCTCAATTATTGTTCATGCTTAAACATATCCATTTGTACAGGCTTATTTCTACGTGGGACCCAATC ATATATACTATATTTCTCAAATAATTTTTCTAAAACTCTGGCCTATATTCTAAACACTTGACCAACACCTTAGTTATTGAATAGGTAACC ATTTTTAAAGTACATGTGGTTCATTTTTTAAAATTCAATCTCTCAAGACCGTTAGATATTTAATAATTTAAGCTGATAAGGGTATCAAAA TGCACATTAACTTTGATCATCATGATTTAAGTTGTAACTTTGTGTTATTATATAAATATTAGGTTGTTTATAAATATATTGCAGAAAGTA TTCTTGTTAAGCTCTTTTAAATGAGGGGACTGTGGTTTAGAGTTATATATTTTTGCTTATTTTTAAACTTCAATTATTCCATTCTTCTGC CTTATAATAAAACTTTTAAGGCAGAGAACTGAACTAATTATAGAATTTCTCCTTTGGAGAGTTATAATGTTACATAGTGAACATTCTTAT AAAAGAAAGAATAAGTTTAAGTTGATGAATATTTAGCTGCAAAGATTTTTTACTTAAAAAAATCCATGAATATCTTTGATTTTATTATAA AGCATTTGTAAATTATTTGCATTTGAGCTGTAAGATTCATAAACATTTACATTTCCCAATGATTTCTATTTTGATTTTTAAAAAATATAC AGGGCAAGCTACATTTTTAAAGCATTAATCAACAACTTTATTATATTACACATTCCAGTGCACAAACACACAATATCATTTAATACTCAC AGTAGTACCTGTGAAATATATCAGATGGATATTCCTATCTCTATTTTACAGCAGAGGAAACCGAAATTCAGAGAACTTACATTTCTAAGG TTGTACAGCTGCAAAATGACCAAATTGTGAAGTCCCTAACATCCAGGTTTTCATAATGCCAGTACTCTTTCTATGACATGTTTATGACCC TCCAAATGTACCAAAACTACCTAACTAATTCACTGAGAGGAAGCCAACTGCAAAAATAGGATTTTTAAAAGTACAATAGAGTATTACTAC ATTTTATGGATTTCAGACAAAGAAACCTCCGTTTATTATATCCTGATGGTGAGTATTGCCAGCTCTAAATTATTCATATTTCTAAGACCA AGGAAAATATAGGTAAATGAAAATTTTGAAATAAAGAACAATGCCTTAATTTGTAAAATCTATCATTGCTACCACCCTGCCCAGGTCTGG >68924_68924_5_PRMT2-SLC41A2_PRMT2_chr21_48069651_ENST00000397638_SLC41A2_chr12_105199115_ENST00000258538_length(amino acids)=279AA_BP=218 MATSGDCPRSESQGEEPAECSEAGLLQEGVQPEEFVAIADYAATDETQLSFLRGEKILILRQTTADWWWGERAGCCGYIPANHVGKHVDE YDPEDTWQDEEYFGSYGTLKLHLEMLADQPRTTKYHSVILQNKESLTDKVILDVGCGTGIISLFCAHYARPRAVYAVEASEMAQHTGQLV LQNGFADIITVYQQKVEDVVLPEKVDVLVSEWMGTCLLVFTLLWIADWMVHHFWRKGKDPDSFSIPYLTALGDLLGTALLALSFHFLWLI -------------------------------------------------------------- >68924_68924_6_PRMT2-SLC41A2_PRMT2_chr21_48069651_ENST00000440086_SLC41A2_chr12_105199115_ENST00000258538_length(transcript)=3578nt_BP=793nt GTGGCTCAGGCTCCTGGAAAGGACCGTCCACCCCTCCGCGCTGGCGGTGTGGACGCGGAACTCAGCGGAGAAACGCGATTGAGAAATGGA AAAGAAAATGAAATAAATCAGCAGTTATGAGGCAGAGCCTAAGAGAACTATGGCAACATCAGGTGACTGTCCCAGAAGTGAATCGCAGGG AGAAGAGCCTGCTGAGTGCAGTGAGGCCGGTCTCCTGCAGGAGGGAGTACAGCCAGAGGAGTTTGTGGCCATCGCGGACTACGCTGCCAC CGATGAGACCCAGCTCAGTTTTTTGAGAGGAGAAAAAATTCTTATCCTGAGACAAACCACTGCAGATTGGTGGTGGGGTGAGCGTGCGGG CTGCTGTGGGTACATTCCGGCAAACCATGTGGGGAAGCACGTGGATGAGTACGACCCCGAGGACACGTGGCAGGATGAAGAGTACTTCGG CAGCTATGGAACTCTGAAACTCCACTTGGAGATGTTGGCAGACCAGCCACGAACAACTAAATACCACAGTGTCATCCTGCAGAATAAAGA ATCCCTGACGGATAAAGTCATCCTGGACGTGGGCTGTGGGACTGGGATCATCAGTCTCTTCTGTGCACACTATGCGCGGCCTAGAGCGGT GTACGCGGTGGAGGCCAGTGAGATGGCACAGCACACGGGGCAGCTGGTCCTGCAGAACGGCTTTGCTGACATCATCACCGTGTACCAGCA GAAGGTGGAGGATGTGGTGCTGCCCGAGAAGGTGGACGTGCTGGTGTCTGAGTGGATGGGGACCTGCCTGCTGGTATTTACCTTGCTGTG GATTGCTGACTGGATGGTCCATCACTTCTGGAGGAAAGGAAAGGACCCGGATAGTTTCTCCATCCCCTACCTAACAGCATTGGGTGATCT GCTCGGGACAGCTCTGTTAGCCTTAAGTTTTCATTTTCTTTGGCTTATTGGAGATCGAGATGGAGATGTTGGAGACTAATAAATTCTACA AACTGCTCTCAAGTTACCAAGGAAGAAAATACACGACAACCACTTATGGCTCTTTTTCAAAACTCTTAAATCAGTAGTTTGACTTTTGCC AGGGTAATCTTCAGTTGGCCCTGATTCAATTAAATGGCCTTAATTTTTTTTTAAGGAATTTGTGTCAAAACCAGAATGAAGAGTATTCGT GCTGCTTTTCATAGAATAAATGATAATTTGACATAGACATAGATATAAGTTCCAGCTCTGAAATTAATTAGGAAAGAATATAGGATGTTT ACAGTGAATAATTTTAAAACCACAAACATAGCAGAAATGTACTTTATTATTAAATTTGTAATGCAGGATTAGAAGAAGCAGAGCTCTAGT TTAGCCTTTCTTGTCTCACAGATGTGCTGTATCCCAGGCATACTATAAAACGAAGAGTGCCCAACCAAGCTTTGAATCGTATTAACAATG CCCACCTCTATGCTAGCTGAGGATAAATTTACCAGTTGCTCATATTTAAACTGACCTAAATATGTTTTGCTGAGCATAAGATAAACTCAC TTTTACCTCCATCTAAAATTATCCTGTTCTGATGCCAATTCAATTTCAGCTCTGCAAGTTCTTGTCAGGCTAATCTTTAAACATTGAGTG ATCTTGAGAGATTGTTAATGAAAGCAGTGAGTCATTTTTTGATGATTGATTTGTTGGAAAAATGTTGATGTGTTTTAAAAAATGTAATCT TCAAAAACAGAATATAACCTGAGATGCATTTGTAGAGACAAGACGGTACGAGAATGTGTGTGTGTGTGTGTGTGAGAGAGAGAGACTTTT GATGAAGAACTAAATCTTGGATTGCTGATAGCAAAGATCATAGTGCTGTTGGAATATCAGCAATATAGAGTTATTCTTAAACACATTCTA TTAACATGTTTTTGTCATTGGGTCCAAAAATTTTGCTGCTGACCAGAATTTACTATTTGTTACCTATATTCTTTTTTTTTTTTTTTTTTT TTTTTTTTGAGACAGAGTCTTGCTCTGTCGCCCAGGCTGGAATGCAGTGGTGTGATCTCGGCTCACTGCTACCTCCACCTCCTGGATTCA AGTGATTCTCCTGCCTCAGCCTCCCGAGTAGCTGGGATTACAGGAATGCGCCACAACGCCCAGCTAATTTGTTACCTACACTCTAATTAA TAATTAATAATTTCTTATTTTAAAAAGTAGTACTATTTAATATAATCAAGATAGGAGATTTAAAATGAGCAAGTGATTCATTTGCTCTTT TAAAGAAGCCCGTTGACTTACGCTTTTAAAAAAGAAGTTGGTGGGTTACCTCAATTATTGTTCATGCTTAAACATATCCATTTGTACAGG CTTATTTCTACGTGGGACCCAATCATATATACTATATTTCTCAAATAATTTTTCTAAAACTCTGGCCTATATTCTAAACACTTGACCAAC ACCTTAGTTATTGAATAGGTAACCATTTTTAAAGTACATGTGGTTCATTTTTTAAAATTCAATCTCTCAAGACCGTTAGATATTTAATAA TTTAAGCTGATAAGGGTATCAAAATGCACATTAACTTTGATCATCATGATTTAAGTTGTAACTTTGTGTTATTATATAAATATTAGGTTG TTTATAAATATATTGCAGAAAGTATTCTTGTTAAGCTCTTTTAAATGAGGGGACTGTGGTTTAGAGTTATATATTTTTGCTTATTTTTAA ACTTCAATTATTCCATTCTTCTGCCTTATAATAAAACTTTTAAGGCAGAGAACTGAACTAATTATAGAATTTCTCCTTTGGAGAGTTATA ATGTTACATAGTGAACATTCTTATAAAAGAAAGAATAAGTTTAAGTTGATGAATATTTAGCTGCAAAGATTTTTTACTTAAAAAAATCCA TGAATATCTTTGATTTTATTATAAAGCATTTGTAAATTATTTGCATTTGAGCTGTAAGATTCATAAACATTTACATTTCCCAATGATTTC TATTTTGATTTTTAAAAAATATACAGGGCAAGCTACATTTTTAAAGCATTAATCAACAACTTTATTATATTACACATTCCAGTGCACAAA CACACAATATCATTTAATACTCACAGTAGTACCTGTGAAATATATCAGATGGATATTCCTATCTCTATTTTACAGCAGAGGAAACCGAAA TTCAGAGAACTTACATTTCTAAGGTTGTACAGCTGCAAAATGACCAAATTGTGAAGTCCCTAACATCCAGGTTTTCATAATGCCAGTACT CTTTCTATGACATGTTTATGACCCTCCAAATGTACCAAAACTACCTAACTAATTCACTGAGAGGAAGCCAACTGCAAAAATAGGATTTTT AAAAGTACAATAGAGTATTACTACATTTTATGGATTTCAGACAAAGAAACCTCCGTTTATTATATCCTGATGGTGAGTATTGCCAGCTCT AAATTATTCATATTTCTAAGACCAAGGAAAATATAGGTAAATGAAAATTTTGAAATAAAGAACAATGCCTTAATTTGTAAAATCTATCAT >68924_68924_6_PRMT2-SLC41A2_PRMT2_chr21_48069651_ENST00000440086_SLC41A2_chr12_105199115_ENST00000258538_length(amino acids)=279AA_BP=218 MATSGDCPRSESQGEEPAECSEAGLLQEGVQPEEFVAIADYAATDETQLSFLRGEKILILRQTTADWWWGERAGCCGYIPANHVGKHVDE YDPEDTWQDEEYFGSYGTLKLHLEMLADQPRTTKYHSVILQNKESLTDKVILDVGCGTGIISLFCAHYARPRAVYAVEASEMAQHTGQLV LQNGFADIITVYQQKVEDVVLPEKVDVLVSEWMGTCLLVFTLLWIADWMVHHFWRKGKDPDSFSIPYLTALGDLLGTALLALSFHFLWLI -------------------------------------------------------------- >68924_68924_7_PRMT2-SLC41A2_PRMT2_chr21_48069651_ENST00000451211_SLC41A2_chr12_105199115_ENST00000258538_length(transcript)=3614nt_BP=829nt GGCCTGCGTGCACTGCGCTTGCGCGGGTTGAGGGCGGTGGCTCAGGCTCCTGGAAAGGACCGTCCACCCCTCCGCGCTGGCGGTGTGGAC GCGGAACTCAGCGGAGAAACGCGATTGAGAAATGGAAAAGAAAATGAAATAAATCAGCAGTTATGAGGCAGAGCCTAAGAGAACTATGGC AACATCAGGTGACTGTCCCAGAAGTGAATCGCAGGGAGAAGAGCCTGCTGAGTGCAGTGAGGCCGGTCTCCTGCAGGAGGGAGTACAGCC AGAGGAGTTTGTGGCCATCGCGGACTACGCTGCCACCGATGAGACCCAGCTCAGTTTTTTGAGAGGAGAAAAAATTCTTATCCTGAGACA AACCACTGCAGATTGGTGGTGGGGTGAGCGTGCGGGCTGCTGTGGGTACATTCCGGCAAACCATGTGGGGAAGCACGTGGATGAGTACGA CCCCGAGGACACGTGGCAGGATGAAGAGTACTTCGGCAGCTATGGAACTCTGAAACTCCACTTGGAGATGTTGGCAGACCAGCCACGAAC AACTAAATACCACAGTGTCATCCTGCAGAATAAAGAATCCCTGACGGATAAAGTCATCCTGGACGTGGGCTGTGGGACTGGGATCATCAG TCTCTTCTGTGCACACTATGCGCGGCCTAGAGCGGTGTACGCGGTGGAGGCCAGTGAGATGGCACAGCACACGGGGCAGCTGGTCCTGCA GAACGGCTTTGCTGACATCATCACCGTGTACCAGCAGAAGGTGGAGGATGTGGTGCTGCCCGAGAAGGTGGACGTGCTGGTGTCTGAGTG GATGGGGACCTGCCTGCTGGTATTTACCTTGCTGTGGATTGCTGACTGGATGGTCCATCACTTCTGGAGGAAAGGAAAGGACCCGGATAG TTTCTCCATCCCCTACCTAACAGCATTGGGTGATCTGCTCGGGACAGCTCTGTTAGCCTTAAGTTTTCATTTTCTTTGGCTTATTGGAGA TCGAGATGGAGATGTTGGAGACTAATAAATTCTACAAACTGCTCTCAAGTTACCAAGGAAGAAAATACACGACAACCACTTATGGCTCTT TTTCAAAACTCTTAAATCAGTAGTTTGACTTTTGCCAGGGTAATCTTCAGTTGGCCCTGATTCAATTAAATGGCCTTAATTTTTTTTTAA GGAATTTGTGTCAAAACCAGAATGAAGAGTATTCGTGCTGCTTTTCATAGAATAAATGATAATTTGACATAGACATAGATATAAGTTCCA GCTCTGAAATTAATTAGGAAAGAATATAGGATGTTTACAGTGAATAATTTTAAAACCACAAACATAGCAGAAATGTACTTTATTATTAAA TTTGTAATGCAGGATTAGAAGAAGCAGAGCTCTAGTTTAGCCTTTCTTGTCTCACAGATGTGCTGTATCCCAGGCATACTATAAAACGAA GAGTGCCCAACCAAGCTTTGAATCGTATTAACAATGCCCACCTCTATGCTAGCTGAGGATAAATTTACCAGTTGCTCATATTTAAACTGA CCTAAATATGTTTTGCTGAGCATAAGATAAACTCACTTTTACCTCCATCTAAAATTATCCTGTTCTGATGCCAATTCAATTTCAGCTCTG CAAGTTCTTGTCAGGCTAATCTTTAAACATTGAGTGATCTTGAGAGATTGTTAATGAAAGCAGTGAGTCATTTTTTGATGATTGATTTGT TGGAAAAATGTTGATGTGTTTTAAAAAATGTAATCTTCAAAAACAGAATATAACCTGAGATGCATTTGTAGAGACAAGACGGTACGAGAA TGTGTGTGTGTGTGTGTGTGAGAGAGAGAGACTTTTGATGAAGAACTAAATCTTGGATTGCTGATAGCAAAGATCATAGTGCTGTTGGAA TATCAGCAATATAGAGTTATTCTTAAACACATTCTATTAACATGTTTTTGTCATTGGGTCCAAAAATTTTGCTGCTGACCAGAATTTACT ATTTGTTACCTATATTCTTTTTTTTTTTTTTTTTTTTTTTTTTTGAGACAGAGTCTTGCTCTGTCGCCCAGGCTGGAATGCAGTGGTGTG ATCTCGGCTCACTGCTACCTCCACCTCCTGGATTCAAGTGATTCTCCTGCCTCAGCCTCCCGAGTAGCTGGGATTACAGGAATGCGCCAC AACGCCCAGCTAATTTGTTACCTACACTCTAATTAATAATTAATAATTTCTTATTTTAAAAAGTAGTACTATTTAATATAATCAAGATAG GAGATTTAAAATGAGCAAGTGATTCATTTGCTCTTTTAAAGAAGCCCGTTGACTTACGCTTTTAAAAAAGAAGTTGGTGGGTTACCTCAA TTATTGTTCATGCTTAAACATATCCATTTGTACAGGCTTATTTCTACGTGGGACCCAATCATATATACTATATTTCTCAAATAATTTTTC TAAAACTCTGGCCTATATTCTAAACACTTGACCAACACCTTAGTTATTGAATAGGTAACCATTTTTAAAGTACATGTGGTTCATTTTTTA AAATTCAATCTCTCAAGACCGTTAGATATTTAATAATTTAAGCTGATAAGGGTATCAAAATGCACATTAACTTTGATCATCATGATTTAA GTTGTAACTTTGTGTTATTATATAAATATTAGGTTGTTTATAAATATATTGCAGAAAGTATTCTTGTTAAGCTCTTTTAAATGAGGGGAC TGTGGTTTAGAGTTATATATTTTTGCTTATTTTTAAACTTCAATTATTCCATTCTTCTGCCTTATAATAAAACTTTTAAGGCAGAGAACT GAACTAATTATAGAATTTCTCCTTTGGAGAGTTATAATGTTACATAGTGAACATTCTTATAAAAGAAAGAATAAGTTTAAGTTGATGAAT ATTTAGCTGCAAAGATTTTTTACTTAAAAAAATCCATGAATATCTTTGATTTTATTATAAAGCATTTGTAAATTATTTGCATTTGAGCTG TAAGATTCATAAACATTTACATTTCCCAATGATTTCTATTTTGATTTTTAAAAAATATACAGGGCAAGCTACATTTTTAAAGCATTAATC AACAACTTTATTATATTACACATTCCAGTGCACAAACACACAATATCATTTAATACTCACAGTAGTACCTGTGAAATATATCAGATGGAT ATTCCTATCTCTATTTTACAGCAGAGGAAACCGAAATTCAGAGAACTTACATTTCTAAGGTTGTACAGCTGCAAAATGACCAAATTGTGA AGTCCCTAACATCCAGGTTTTCATAATGCCAGTACTCTTTCTATGACATGTTTATGACCCTCCAAATGTACCAAAACTACCTAACTAATT CACTGAGAGGAAGCCAACTGCAAAAATAGGATTTTTAAAAGTACAATAGAGTATTACTACATTTTATGGATTTCAGACAAAGAAACCTCC GTTTATTATATCCTGATGGTGAGTATTGCCAGCTCTAAATTATTCATATTTCTAAGACCAAGGAAAATATAGGTAAATGAAAATTTTGAA ATAAAGAACAATGCCTTAATTTGTAAAATCTATCATTGCTACCACCCTGCCCAGGTCTGGCCATTTGCCATAAATGCTGGTAAATAAATA >68924_68924_7_PRMT2-SLC41A2_PRMT2_chr21_48069651_ENST00000451211_SLC41A2_chr12_105199115_ENST00000258538_length(amino acids)=279AA_BP=218 MATSGDCPRSESQGEEPAECSEAGLLQEGVQPEEFVAIADYAATDETQLSFLRGEKILILRQTTADWWWGERAGCCGYIPANHVGKHVDE YDPEDTWQDEEYFGSYGTLKLHLEMLADQPRTTKYHSVILQNKESLTDKVILDVGCGTGIISLFCAHYARPRAVYAVEASEMAQHTGQLV LQNGFADIITVYQQKVEDVVLPEKVDVLVSEWMGTCLLVFTLLWIADWMVHHFWRKGKDPDSFSIPYLTALGDLLGTALLALSFHFLWLI -------------------------------------------------------------- >68924_68924_8_PRMT2-SLC41A2_PRMT2_chr21_48069651_ENST00000458387_SLC41A2_chr12_105199115_ENST00000258538_length(transcript)=3614nt_BP=829nt GGCCTGCGTGCACTGCGCTTGCGCGGGTTGAGGGCGGTGGCTCAGGCTCCTGGAAAGGACCGTCCACCCCTCCGCGCTGGCGGTGTGGAC GCGGAACTCAGCGGAGAAACGCGATTGAGAAATGGAAAAGAAAATGAAATAAATCAGCAGTTATGAGGCAGAGCCTAAGAGAACTATGGC AACATCAGGTGACTGTCCCAGAAGTGAATCGCAGGGAGAAGAGCCTGCTGAGTGCAGTGAGGCCGGTCTCCTGCAGGAGGGAGTACAGCC AGAGGAGTTTGTGGCCATCGCGGACTACGCTGCCACCGATGAGACCCAGCTCAGTTTTTTGAGAGGAGAAAAAATTCTTATCCTGAGACA AACCACTGCAGATTGGTGGTGGGGTGAGCGTGCGGGCTGCTGTGGGTACATTCCGGCAAACCATGTGGGGAAGCACGTGGATGAGTACGA CCCCGAGGACACGTGGCAGGATGAAGAGTACTTCGGCAGCTATGGAACTCTGAAACTCCACTTGGAGATGTTGGCAGACCAGCCACGAAC AACTAAATACCACAGTGTCATCCTGCAGAATAAAGAATCCCTGACGGATAAAGTCATCCTGGACGTGGGCTGTGGGACTGGGATCATCAG TCTCTTCTGTGCACACTATGCGCGGCCTAGAGCGGTGTACGCGGTGGAGGCCAGTGAGATGGCACAGCACACGGGGCAGCTGGTCCTGCA GAACGGCTTTGCTGACATCATCACCGTGTACCAGCAGAAGGTGGAGGATGTGGTGCTGCCCGAGAAGGTGGACGTGCTGGTGTCTGAGTG GATGGGGACCTGCCTGCTGGTATTTACCTTGCTGTGGATTGCTGACTGGATGGTCCATCACTTCTGGAGGAAAGGAAAGGACCCGGATAG TTTCTCCATCCCCTACCTAACAGCATTGGGTGATCTGCTCGGGACAGCTCTGTTAGCCTTAAGTTTTCATTTTCTTTGGCTTATTGGAGA TCGAGATGGAGATGTTGGAGACTAATAAATTCTACAAACTGCTCTCAAGTTACCAAGGAAGAAAATACACGACAACCACTTATGGCTCTT TTTCAAAACTCTTAAATCAGTAGTTTGACTTTTGCCAGGGTAATCTTCAGTTGGCCCTGATTCAATTAAATGGCCTTAATTTTTTTTTAA GGAATTTGTGTCAAAACCAGAATGAAGAGTATTCGTGCTGCTTTTCATAGAATAAATGATAATTTGACATAGACATAGATATAAGTTCCA GCTCTGAAATTAATTAGGAAAGAATATAGGATGTTTACAGTGAATAATTTTAAAACCACAAACATAGCAGAAATGTACTTTATTATTAAA TTTGTAATGCAGGATTAGAAGAAGCAGAGCTCTAGTTTAGCCTTTCTTGTCTCACAGATGTGCTGTATCCCAGGCATACTATAAAACGAA GAGTGCCCAACCAAGCTTTGAATCGTATTAACAATGCCCACCTCTATGCTAGCTGAGGATAAATTTACCAGTTGCTCATATTTAAACTGA CCTAAATATGTTTTGCTGAGCATAAGATAAACTCACTTTTACCTCCATCTAAAATTATCCTGTTCTGATGCCAATTCAATTTCAGCTCTG CAAGTTCTTGTCAGGCTAATCTTTAAACATTGAGTGATCTTGAGAGATTGTTAATGAAAGCAGTGAGTCATTTTTTGATGATTGATTTGT TGGAAAAATGTTGATGTGTTTTAAAAAATGTAATCTTCAAAAACAGAATATAACCTGAGATGCATTTGTAGAGACAAGACGGTACGAGAA TGTGTGTGTGTGTGTGTGTGAGAGAGAGAGACTTTTGATGAAGAACTAAATCTTGGATTGCTGATAGCAAAGATCATAGTGCTGTTGGAA TATCAGCAATATAGAGTTATTCTTAAACACATTCTATTAACATGTTTTTGTCATTGGGTCCAAAAATTTTGCTGCTGACCAGAATTTACT ATTTGTTACCTATATTCTTTTTTTTTTTTTTTTTTTTTTTTTTTGAGACAGAGTCTTGCTCTGTCGCCCAGGCTGGAATGCAGTGGTGTG ATCTCGGCTCACTGCTACCTCCACCTCCTGGATTCAAGTGATTCTCCTGCCTCAGCCTCCCGAGTAGCTGGGATTACAGGAATGCGCCAC AACGCCCAGCTAATTTGTTACCTACACTCTAATTAATAATTAATAATTTCTTATTTTAAAAAGTAGTACTATTTAATATAATCAAGATAG GAGATTTAAAATGAGCAAGTGATTCATTTGCTCTTTTAAAGAAGCCCGTTGACTTACGCTTTTAAAAAAGAAGTTGGTGGGTTACCTCAA TTATTGTTCATGCTTAAACATATCCATTTGTACAGGCTTATTTCTACGTGGGACCCAATCATATATACTATATTTCTCAAATAATTTTTC TAAAACTCTGGCCTATATTCTAAACACTTGACCAACACCTTAGTTATTGAATAGGTAACCATTTTTAAAGTACATGTGGTTCATTTTTTA AAATTCAATCTCTCAAGACCGTTAGATATTTAATAATTTAAGCTGATAAGGGTATCAAAATGCACATTAACTTTGATCATCATGATTTAA GTTGTAACTTTGTGTTATTATATAAATATTAGGTTGTTTATAAATATATTGCAGAAAGTATTCTTGTTAAGCTCTTTTAAATGAGGGGAC TGTGGTTTAGAGTTATATATTTTTGCTTATTTTTAAACTTCAATTATTCCATTCTTCTGCCTTATAATAAAACTTTTAAGGCAGAGAACT GAACTAATTATAGAATTTCTCCTTTGGAGAGTTATAATGTTACATAGTGAACATTCTTATAAAAGAAAGAATAAGTTTAAGTTGATGAAT ATTTAGCTGCAAAGATTTTTTACTTAAAAAAATCCATGAATATCTTTGATTTTATTATAAAGCATTTGTAAATTATTTGCATTTGAGCTG TAAGATTCATAAACATTTACATTTCCCAATGATTTCTATTTTGATTTTTAAAAAATATACAGGGCAAGCTACATTTTTAAAGCATTAATC AACAACTTTATTATATTACACATTCCAGTGCACAAACACACAATATCATTTAATACTCACAGTAGTACCTGTGAAATATATCAGATGGAT ATTCCTATCTCTATTTTACAGCAGAGGAAACCGAAATTCAGAGAACTTACATTTCTAAGGTTGTACAGCTGCAAAATGACCAAATTGTGA AGTCCCTAACATCCAGGTTTTCATAATGCCAGTACTCTTTCTATGACATGTTTATGACCCTCCAAATGTACCAAAACTACCTAACTAATT CACTGAGAGGAAGCCAACTGCAAAAATAGGATTTTTAAAAGTACAATAGAGTATTACTACATTTTATGGATTTCAGACAAAGAAACCTCC GTTTATTATATCCTGATGGTGAGTATTGCCAGCTCTAAATTATTCATATTTCTAAGACCAAGGAAAATATAGGTAAATGAAAATTTTGAA ATAAAGAACAATGCCTTAATTTGTAAAATCTATCATTGCTACCACCCTGCCCAGGTCTGGCCATTTGCCATAAATGCTGGTAAATAAATA >68924_68924_8_PRMT2-SLC41A2_PRMT2_chr21_48069651_ENST00000458387_SLC41A2_chr12_105199115_ENST00000258538_length(amino acids)=279AA_BP=218 MATSGDCPRSESQGEEPAECSEAGLLQEGVQPEEFVAIADYAATDETQLSFLRGEKILILRQTTADWWWGERAGCCGYIPANHVGKHVDE YDPEDTWQDEEYFGSYGTLKLHLEMLADQPRTTKYHSVILQNKESLTDKVILDVGCGTGIISLFCAHYARPRAVYAVEASEMAQHTGQLV LQNGFADIITVYQQKVEDVVLPEKVDVLVSEWMGTCLLVFTLLWIADWMVHHFWRKGKDPDSFSIPYLTALGDLLGTALLALSFHFLWLI -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for PRMT2-SLC41A2 |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
Hgene | PRMT2 | chr21:48069651 | chr12:105199115 | ENST00000334494 | + | 6 | 7 | 83_207 | 218.0 | 285.0 | RB1 |
Hgene | PRMT2 | chr21:48069651 | chr12:105199115 | ENST00000355680 | + | 7 | 12 | 83_207 | 218.0 | 434.0 | RB1 |
Hgene | PRMT2 | chr21:48069651 | chr12:105199115 | ENST00000397637 | + | 6 | 11 | 83_207 | 218.0 | 434.0 | RB1 |
Hgene | PRMT2 | chr21:48069651 | chr12:105199115 | ENST00000397638 | + | 6 | 11 | 83_207 | 218.0 | 434.0 | RB1 |
Hgene | PRMT2 | chr21:48069651 | chr12:105199115 | ENST00000440086 | + | 6 | 9 | 83_207 | 218.0 | 332.0 | RB1 |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Hgene | PRMT2 | chr21:48069651 | chr12:105199115 | ENST00000334494 | + | 6 | 7 | 133_275 | 218.0 | 285.0 | ESR1 |
Hgene | PRMT2 | chr21:48069651 | chr12:105199115 | ENST00000334494 | + | 6 | 7 | 1_277 | 218.0 | 285.0 | ESR1 |
Hgene | PRMT2 | chr21:48069651 | chr12:105199115 | ENST00000355680 | + | 7 | 12 | 133_275 | 218.0 | 434.0 | ESR1 |
Hgene | PRMT2 | chr21:48069651 | chr12:105199115 | ENST00000355680 | + | 7 | 12 | 1_277 | 218.0 | 434.0 | ESR1 |
Hgene | PRMT2 | chr21:48069651 | chr12:105199115 | ENST00000397637 | + | 6 | 11 | 133_275 | 218.0 | 434.0 | ESR1 |
Hgene | PRMT2 | chr21:48069651 | chr12:105199115 | ENST00000397637 | + | 6 | 11 | 1_277 | 218.0 | 434.0 | ESR1 |
Hgene | PRMT2 | chr21:48069651 | chr12:105199115 | ENST00000397638 | + | 6 | 11 | 133_275 | 218.0 | 434.0 | ESR1 |
Hgene | PRMT2 | chr21:48069651 | chr12:105199115 | ENST00000397638 | + | 6 | 11 | 1_277 | 218.0 | 434.0 | ESR1 |
Hgene | PRMT2 | chr21:48069651 | chr12:105199115 | ENST00000440086 | + | 6 | 9 | 133_275 | 218.0 | 332.0 | ESR1 |
Hgene | PRMT2 | chr21:48069651 | chr12:105199115 | ENST00000440086 | + | 6 | 9 | 1_277 | 218.0 | 332.0 | ESR1 |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for PRMT2-SLC41A2 |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for PRMT2-SLC41A2 |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |